Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

November 30, 2002

Conditions
Febrile Neutropenia
Interventions
DRUG

linezolid

600mg every 12 hours

DRUG

vancomycin

1gm every 12 hours. The dose of vancomycin intravenously may be adjusted for renal function, but the patient must be able to receive a 300 mL volume of intravenous fluid at the assigned dosing times of every 12 hours.

Trial Locations (40)

13

Pfizer Investigational Site, Lima

34

Pfizer Investigational Site, Lima

1020

Pfizer Investigational Site, Caracas

1041

Pfizer Investigational Site, Caracas

1094

Pfizer Investigational Site, Buenos Aires

5000

Pfizer Investigational Site, Córdoba

5500

Pfizer Investigational Site, Mendoza

10461

Pfizer Investigational Site, The Bronx

10467

Pfizer Investigational Site, The Bronx

23226

Pfizer Investigational Site, Richmond

23229

Pfizer Investigational Site, Richmond

23249

Pfizer Investigational Site, Richmond

23294

Pfizer Investigational Site, Richmond

45173

Pfizer Investigational Site, Zapopan

62703

Pfizer Investigational Site, Springfield

62769

Pfizer Investigational Site, Springfield

62781

Pfizer Investigational Site, Springfield

74800

Pfizer Investigational Site, Karachi

77030

Pfizer Investigational Site, Houston

90033

Pfizer Investigational Site, Los Angeles

98003

Pfizer Investigational Site, Federal Way

98405

Pfizer Investigational Site, Tacoma

98499

Pfizer Investigational Site, Lakewood

62701-1014

Pfizer Investigational Site, Springfield

23294-4367

Pfizer Investigational Site, Richmond

90020-090

Pfizer Investigational Site, Porto Alegre

90610-000

Pfizer Investigational Site, Porto Alegre

01409-902

Pfizer Investigational Site, São Paulo

01509-900

Pfizer Investigational Site, São Paulo

04024-002

Pfizer Investigational Site, São Paulo

05651-901

Pfizer Investigational Site, São Paulo

Unknown

Pfizer Investigational Site, Santiago

Pfizer Investigational Site, Bogotá

Pfizer Investigational Site, Medellín

Pfizer Investigational Site, Lahore

Pfizer Investigational Site

NAP

Pfizer Investigational Site, Bogotá

FIN-00029 HYKS

Pfizer Investigational Site, Helsinki

C.P. 64000

Pfizer Investigational Site, Monterrey

C.P. 02990

Pfizer Investigational Site, Mexico City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY